Skip to main content

Featured

The Bank of Canada Warns of Higher Inflation: What It Means for Your Money

  The Bank of Canada Warns of Higher Inflation: What It Means for Your Money October 29, 2026 | Canadian Money Brief Canadians could face another year of rising living costs. Here's how to protect your savings, manage your grocery bill and make smarter financial decisions. If you thought inflation was finally becoming yesterday's problem, the Bank of Canada's latest forecast delivers an important reminder: the cost of living could remain under pressure well into next year. In its October 28, 2026, Monetary Policy Report, the Bank of Canada warned that inflation is expected to remain above 3% through much of 2027 before gradually returning close to its 2% target by the middle of 2028. Higher energy prices, rising import costs and trade uncertainty are contributing to the outlook. The Bank also raised its overnight policy rate by 0.25 percentage points to 2.50% in an effort to contain inflationary pressures. For Canadian households, the message is clear: even if inflation eve...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments